Metastatic Microsatellite-stable Colorectal Cancer Clinical Trials

7 clinical trials for Metastatic Microsatellite-stable Colorectal Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients — RECRUITING · PHASE1
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — RECRUITING · PHASE3
• Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC — RECRUITING · PHASE3
• COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC — ACTIVE_NOT_RECRUITING · PHASE1
• Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma — OTHER · PHASE2
• Nivolumab+Ipilimumab+RT in MSS mCRC — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search